Navigation Links
Thinking makes it so: Science extends reach of prosthetic arms
Date:11/10/2007

BETHESDA, Md. − Motorized prosthetic arms can help amputees regain some function, but these devices take time to learn to use and are limited in the number of movements they provide.

Todd A. Kuiken, M.D., Ph.D., a physiatrist at the Rehabilitation Institute of Chicago and professor at Northwestern University, has pioneered a technique known as targeted muscle reinnervation (TMR), which allows a prosthetic arm to respond directly to the brains signals, making it much easier to use than traditional motorized prosthetics. This technique, still under development, allows wearers to open and close their artificial hands and bend and straighten their artificial elbows nearly as naturally as their own arms.

The idea is that when you lose your arm, you lose the motors, the muscles and the structural elements of the bones, Kuiken explained. But the control information should still be there in the residual nerves. He decided to take the residual nerves, which once carried the commands from the brain to produce arm, wrist and hand movements, and connect them to the chest muscles so that the signals can be used to move the artificial limb.

Nearly a dozen patients who have undergone TMR so far have motorized prosthetic arms that produce two arm movements: open and close hand and bend and straighten elbow. But in a new study from the Journal of Neurophysiology, published by The American Physiological Society, Kuiken and his colleagues demonstrate that TMR has the potential to provide an even greater number of arm and hand movements, beyond the four theyve already achieved. The researchers have begun work with two U.S. Army medical centers to help soldiers who have lost limbs.

The study, entitled Decoding a new neural-machine interface for control of artificial limbs, was conducted by Ping Zhou, Madeleine M. Lowery, Kevin B. Englehart, He Huang, Guanglin Li, Levi Hargrove, Julius P.A. Dewald and Kuiken, all of Northwestern University
'/>"/>

Contact: Christine Guilfoy
cguilfoy@the-aps.org
301-634-7253
American Physiological Society
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Exercise improves thinking, reduces diabetes risk in overweight children
2. New drug makes weight loss safer
3. How mother of thousands makes plantlets
4. For honey bee queens, multiple mating makes a difference
5. Scientists spy enzyme that makes us unique
6. News tips from the Journal of Neuroscience
7. e-Science points to pollution solutions
8. 4,000 e-Books now available on ScienceDirect
9. UCI receives $5M from Edwards Lifesciences
10. Singapore National Science and Technology Awards
11. Planetary geoscience, paleontology, and more at GSA Annual Meeting in Denver next month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...y of West African chimpanzees living in Cte d,Ivoi...pecies has dropped in numbers by a whopping 90 per...ago. The few remaining chimpanzees are now highly ... in Ta National Park, according to a report in the...ress publication. , This alarming decline in a c...
(Date:10/13/2008)... reveal why different parts of the brain can come ...MS). According to a new study in mice with an MS-l...duced by invading T cells dictates whether it,s th... The studyfrom researchers at the University of Ma...ton University in St. Louiswill be published onlin...
(Date:10/12/2008)...o available in French . , Researchers at McGi...hKline Inc. have identified two genetic variants i...evenfold increase the risk of male pattern baldnes...journal Nature Genetics. , About a third of al... 45. The condition,s social and economic impact is...
(Date:10/10/2008)... -- In a groundbreaking study led by an eminent mo...earchers have discovered that as embryonic stem ce...atic corresponding changes to the order in which D... bridge a critical knowledge gap for stem cell bio...ormously complex process by which DNA is repackage...
Breaking Biology News(10 mins):In a last 'stronghold' for endangered chimpanzees, survey finds drastic decline 2Researchers discover baldness gene: 1 in 7 men at risk 2Landmark study unlocks stem cell, DNA secrets to speed therapies 2Landmark study unlocks stem cell, DNA secrets to speed therapies 3Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2008 Results 15714 1Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 1Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 2Running Pioneer Kathrine Switzer Will Headline Women on the Move Conference August 13 15 2008 in Spearfish SD 15711 3MiMedx Group Announces Post split Name Change 4339 1MiMedx Group Announces Post split Name Change 4339 2MiMedx Group Announces Post split Name Change 4339 3Restrictive Prescription Drug Policies Hurt Schizophrenics 15708 1Restrictive Prescription Drug Policies Hurt Schizophrenics 15708 2
...minated this week by the continuing debate over HI...mang repeated yet again that drugs were not the on...ere also important. , After previously denying li...ment began providing AIDS drugs in clinics last ye... positive, which is more than any other nationalit...
...noma, studying functional tissue rather than cell ...s development, according to new research from a Ho...t Stanford University School of Medicine. , Though...melanoma development, scientists have not been abl...alterations and human cancer growth. Determining w...
...noma, studying functional tissue rather than cell ...s development, according to new research from a Ho...t Stanford University School of Medicine. , Though...melanoma development, scientists have not been abl...alterations and human cancer growth. Determining w...
...tistically significant improvements in clinical me...sia on the Etiology, Pathogenesis and Treatment of...eurologix,s Phase I trial showed positive interim ... year following treatment, patients exhibited a st...ion on the side of their body correlating to the t...
Other Biology News:Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 2Researchers use RNAi libraries to identify regulators of apoptosis and chemoresistance 3Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack 2Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 2Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 4Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 5Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 6
(Date:10/14/2008)... China, Oct. 14 /Xinhua--,C...ina-Biotics", "the,Company"), a leading Chinese fi...lopment, marketing and distribution of probiotics ... to list its common stock on the,Nasdaq Global Mar...he Nasdaq on October 23,2008, until which time it...
(Date:10/14/2008)... Va., Oct. 14 /- Insmed Inc...ogics and biopharmaceuticals, today,announced that...reverse,stock split, if necessary, at a Special Me...effort to meet the minimum bid price rule for cont...tember 3, 2008, the Company announced that the NAS...
(Date:10/14/2008)... China, Oct. 14 /Xinhua-- WuXi Pharma...eutical, biotechnology and,medical device research...ns,in China and the United States, today announced...for the third quarter ended September 30, 2008,an...Logo: http://www.newscom.com/cgi-bin/prnh/2004070...
(Date:10/13/2008)...ES, Oct. 13 /- Vista Partners announc...can Bio Medica Corporation,(Nasdaq: ABMC ) and ma...ss,Silver, Director of Research at Vista Partners ...e and sales from the Company,s lab,alliance, which... centers,continue to increase as well. The Compan...
Breaking Biology Technology:China-Biotics, Inc. Approved to List on the Nasdaq Global Market 2Insmed to Seek Shareholder Approval for Reverse Split 2Insmed to Seek Shareholder Approval for Reverse Split 3WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 2WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 3WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 4WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 5WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 6WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 7WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 8Vista Partners Updates Coverage; Maintains $3.20 Target Price 2
...ulk and custom kits made-to-order , Cust... Stringent quality control guaranteed , ... , Ambion Custom has a staff of R&D and ... plan your research and design products specifical...oduct can be customized. You specify the volumes a...
...lencer Validated siRNAs are single siRNA duplexes ...-PCR to reduce the expression of a number of impor... validation is a >70% reduction in , targ...ugh the average , reduction in target gen... , is greater than 90%. Every Silencer Va...
... , , , Application Gu........................................................on .................................................................................2 , II. P........................................................
...lication Guide, ,I. Description ,II. Prod...by the User ,IV. Protocol for Extraction of DN...Genome Amplification from Soil ,VI. Quantifica...of Amplified Products , ,Appendix, , R...,Application Guide, , I. Description ,T...
Other Biology Technology:Ambion Custom: Made-to-Order 2Ambion Custom: Made-to-Order 3Silencer Validated siRNAs 2Silencer Validated siRNAs 3Silencer Validated siRNAs 4Silencer Validated siRNAs 5Silencer Validated siRNAs 6Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 2Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 3Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 4Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 5Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 6Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 7Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 8Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 9Protocol for GenomePlex Whole Genome Amplification from Soil 2Protocol for GenomePlex Whole Genome Amplification from Soil 3Protocol for GenomePlex Whole Genome Amplification from Soil 4Protocol for GenomePlex Whole Genome Amplification from Soil 5
capacity 250 mL
Rabbit polyclonal to MSY2/YBOX2 ( Abpromise for all tested applications). Antigen: Synthetic peptide derived from a region between amino acids 178-227 of human YBX2. (Note: the exact amino acid
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z35,347-7) or contact custom
Standard Fluka For microscopy (Bact., Hist.)
Biology Products: